共查询到20条相似文献,搜索用时 15 毫秒
1.
目的:探讨子宫内膜异位症患者血清可溶性B7-H4(sB7-H4)的水平及其临床意义。方法:用ELISA夹心法检测43例子宫内膜异位症患者术前血清sB7-H4的水平及40例子宫内膜异位症患者术后血清sB7-H4的水平,同时选取30例体检健康妇女血清sB7-H4水平作为对照。结果:子宫内膜异位症患者血清sB7-H4水平为(36.23±5.67)μg/L,体检健康者血清sB7-H4水平为(31.24±4.56)μg/L,两者比较差异有统计学意义(P0.01)。手术前,子宫内膜异位症患者血清sB7-H4水平为(36.23±5.67)μg/L,明显高于术后(32.54±4.27)μg/L(P0.05)。子宫内膜异位症患者血清sB7-H4水平与CA125水平呈显著正相关(r=0.531,P0.01)。结论:血清可溶性B7-H4可能与子宫内膜异位症的发病有关,检测血清中可溶性B7-H4水平对内异症的辅助诊断和疗效观察可能具有一定的临床意义。 相似文献
2.
Tai-Wei Sun Qiang Gao Shuang-Jian Qiu Jian Zhou Xiao-Ying Wang Yong Yi Jie-Yi Shi Yong-Feng Xu Ying-Hong Shi Kang Song Yong-Sheng Xiao Jia Fan 《Cancer immunology, immunotherapy : CII》2012,61(11):2171-2182
B7-H3, a novel B7 family member, positively or negatively regulates T-cell responses. We investigated the clinical relevance and prognostic significance of B7-H3 in hepatocellular carcinoma (HCC). Western blotting showed B7-H3 upregulation in 17 of 24 (70.8 %) HCC tissues compared with nontumor liver tissues (p = 0.028). B7-H3 immunostaining on tissue microarrays containing 240 HCC patient samples indicated that 225 (93.8 %) tumors had aberrant B7-H3 expression, with strong intensity in 79 (32.9 %) cases, whereas B7-H3 expression in peritumor liver cells was weak in most cases (226; 94.2 %). Notably, patients with high/moderate tumor cell B7-H3 expression showed significantly poorer survival (p = 0.009) and increased recurrence (p = 0.002). After multivariable adjustment, high/moderate B7-H3 expression remained significant for an increased risk of recurrence (hazard ratio = 1.79; 95 % confidence interval = 1.19–2.70; p = 0.005). B7-H3 expression correlated with invasive phenotypes like vascular invasion and advanced tumor stage, and the metastatic potential of HCC cell lines. Flow cytometry showed that B7-H3 expression is inversely correlated with proliferation and interferon-γ production by infiltrating T cells. Interferon-γ stimulation significantly upregulated B7-H3 expression in HCC cells in vitro, implicating B7-H3 expression as a feedback mechanism to evade anti-tumor immunity. Importantly, the prognostic value of B7-H3 expression was validated in an independent cohort of 206 HCC patients. Collectively, our data suggest that B7-H3 was abundantly expressed in HCC and was associated with adverse clinicopathologic features and poor outcome. Thus, B7-H3 represents an attractive target for diagnostic and therapeutic manipulation in human HCC. 相似文献
3.
Characterization of mouse and human B7-H3 genes 总被引:13,自引:0,他引:13
Sun M Richards S Prasad DV Mai XM Rudensky A Dong C 《Journal of immunology (Baltimore, Md. : 1950)》2002,168(12):6294-6297
T cell activation and immune function are regulated by costimulatory molecules of the B7 superfamily. Human B7-H3 is a recent addition to this family and has been shown to mediate T cell proliferation and IFN-gamma production. In this work we describe the identification of the mouse B7-H3 homolog, which is ubiquitously expressed in a variety of tissues. Activated CD4 and CD8 T cells express a putative receptor that can be recognized by soluble mouse B7-H3-Ig molecules. While the mouse B7-H3 gene was found to contain a single copy, we discovered a novel isoform of human B7-H3 (named as B7-H3b hereafter) with four Ig-like domains that results from gene duplication and differential splicing. B7-H3b is the major isoform expressed in several tissues. This structural information suggests a genetic variation of the B7-H3 gene in mammalian species. 相似文献
4.
Jing Sun Lu-jun Chen Guang-bo Zhang Jing-ting Jiang Ming Zhu Yan Tan Hai-tao Wang Bin-feng Lu Xue-guang Zhang 《Cancer immunology, immunotherapy : CII》2010,59(8):1163-1171
B7-H3, a member of the B7-family molecules, plays an important role in adaptive immune responses, and was shown to either
promote or inhibit T-cell responses in various experimental systems. B7-H3 was expressed in some human cancers and correlated
with poor outcome of cancer patients. However, its exact role in cancer is not known. In the present study, we studied the
expression of B7-H3 in the pathologic specimens of 102 patients treated for colorectal carcinoma (CRC) by immunohistochemistry.
Strong B7-H3 expression was found in cancer tissues from 54.3% CRC patients, while minimal expression was found in adjacent
normal colorectal tissues. Higher B7-H3 expression in tumor positively correlated with a more advanced tumor grade. In addition,
consistent with a role of B7-H3 in suppressing tumor immune surveillance, the expression of B7-H3 in cancer cells negatively
correlated with the intensity of tumor infiltrating T lymphocytes in both tumor nest and tumor stroma. Furthermore, we found
that the level of soluble B7-H3 in sera from CRC patients was higher than healthy donors. TNF-α, an important cancer-promoting
inflammatory molecule, was subsequently found to significantly increase the release of soluble B7-H3 in colon cancer cell
lines. Therefore, our data suggest that both soluble and membranous B7-H3 proteins are involved in colon cancer progression
and evasion of cancer immune surveillance. 相似文献
5.
目的:探讨肝细胞癌(HCC)患者血清B7-H4水平及其临床意义。方法:采用ELISA方法检测和比较116例HCC患者和60例健康对照人群的血清B7-H4水平,并分析血清B7-H4水平和HCC患者临床参数和生存情况的关系。结果:(1)HCC患者的血清B7-H4水平显著高于健康对照组(P0.001);(2)血清B7-H4水平与HCC患者血清AFP水平(r=0.653,P=0.012)和TNM分期(r=0.713,P=0.003)相关;(3)高血清B7-H4组HCC患者5年总体生存率较低血清B7-H4组显著降低(P=0.028);(4)血清B7-H4水平是HCC预后的独立预测因子(P=0.034)。结论:HCC患者的血清B7-H4水平显著上调,对于HCC的诊断及预后判断具有重要的参考意义。 相似文献
6.
本研究选取2015年3月至2017年5月在我院保存的胆囊癌标本55例,同选取癌旁正常组织(距癌边缘>5 cm)作为对照,采用免疫组化染色检测B7-H1和B7-H3蛋白表达,分析B7-H1和B7-H3表达与胆囊癌临床病理特征和预后的关系,探讨共刺激因子B7-H1和B7-H3蛋白在胆囊癌中的表达及意义。研究结果表明:胆囊癌组织B7-H1和B7-H3蛋白阳性表达率分别为76.36%和63.63%,明显高于癌旁组织(p<0.05);B7-H1蛋白表达与胆囊癌TNM分期、淋巴结转移和侵袭深度有关(p<0.05);B7-H3蛋白表达与胆囊癌TNM分期、分化程度、淋巴结转移和侵袭深度有关(p<0.05);胆囊癌组织中B7-H1与B7-H3蛋白表达呈正相关(rs=0.516, p<0.05);B7-H1和B7-H3表达双阳性者和B7-H1或B7-H3单一表达阳性者中位总生存时间分别为20个月和21个月,明显低于B7-H1和B7-H3表达双阴性者组,差异比较有统计学意义(p<0.05)。本研究结论认为:B7-H1和B7-H3蛋白表达与胆囊癌病理特征有关系,两者间有一定相关性,且与患者预后有关。 相似文献
7.
B7-H3, a recently identified B7 family member, has different isoforms in human and mouse. Mouse B7-H3 gene has only one isoform (2IgB7-H3) with two Ig-like domains, whereas human B7-H3 has two isoforms (2IgB7-H3 and 4IgB7-H3). In this study a systematic genomic survey across various species from teleost fishes to mammals revealed that 4IgB7-H3 isoform also appeared in pigs, guinea pigs, cows, dogs, African elephants, pandas, megabats and higher primate animals, which resulted from tandem exon duplication. Further sequence analysis indicated that this duplication generated a new conserved region in the first IgC domain, which might disable 4IgB7-H3 from releasing soluble form, while 2IgB7-H3 presented both membrane and soluble forms. Through three-dimensional (3D) structure modeling and fusion-protein binding assays, we discovered that the duplicated isoform had a different structure and might bind to another potential receptor on activated T cells. In T cell proliferation assay, human 2IgB7-H3 (h2IgB7-H3) and mouse B7-H3 (mB7-H3) both increased T cell proliferation and IL-2, IFN-γ production, whereas human 4IgB7-H3 (h4IgB7-H3) reduced cytokine production and T cell proliferation compared to control. Furthermore, both h2IgB7-H3 and mB7-H3 upregulated the function of lipopolysacharide (LPS)-activated monocyte in vitro. Taken together, our data implied that during the evolution of vertebrates, B7-H3 exon duplication contributed to the generation of a new 4IgB7-H3 isoform in many mammalian species, which have carried out distinct functions in the immune responses. 相似文献
8.
Chen J Li G Meng H Fan Y Song Y Wang S Zhu F Guo C Zhang L Shi Y 《Cancer immunology, immunotherapy : CII》2012,61(1):101-108
The overexpression of B7-H1 in hepatocellular carcinoma (HCC) mediates HCC immune escape and obstructs the immunotherapy based
on tumor-specific CD8+ T cells. Tumor-associated macrophages (TAM) are a major component of cancer-related inflammation and
play a central role in tumor promotion. To classify the mechanism underlying the overexpression of B7-H1 in HCC, we examined
B7-H1 expression and TAM infiltration in 63 cases of human HCC samples using immunohistochemistry method and found that B7-H1
overexpression was associated with TAM infiltration in HCC tissues. Furthermore, B7-H1 expression was upregulated at both
mRNA level and protein level in HCC cells (BEL-7402 and SMMC-7721) cocultured with macrophages in a transwell system. The
upregulation of B7-H1 expression induced by macrophage was inhibited by blocking NF-κB or STAT3 signal pathways. These results
suggest that overexpression of B7-H1 in HCC may be induced by inflammatory microenvironment involving macrophages and imply
that anti-inflammation therapy might be preventive for immune escape and assistant for immunotherapy of HCC. 相似文献
9.
《Biomarkers》2013,18(4):271-274
AbstractObjective: To evaluate the diagnostic value of sB7-H4 and CEA in both serum and pleural effusion of lung cancer patients.Methods: Levels of sB7-H4 and CEA in 90 patients with malignant pleural effusion due to lung cancer and 58 patients with benign pleural effusion were measured by ELISA.Results: The sB7-H4 and CEA levels in pleural effusion, serum and their ratio (F/S) were higher in lung cancer group than that in benign group (p?<?0.01). The diagnostic efficiency of sB7-H4 combined CEA was superior to either sB7-H4 or CEA.Conclusions: Measurement of sB7-H4 and CEA might be useful diagnostic value for malignant effusion. 相似文献
10.
摘要 目的:观察肝动脉化疗栓塞术(TACE)联合碘125粒子植入治疗原发性肝癌(PHC)合并门静脉癌栓(PVTT)的疗效及对血清恶性肿瘤特异性生长因子(TSGF)、胸苷激酶1(TK-1)、可溶性B7-H3(sB7-H3)的影响。方法:选择新疆医科大学附属肿瘤医院2019年1月到2020年1月期间收治的PHC合并PVTT患者120例,按照随机数字表法分为对照组(TACE治疗,60例)和联合组(TACE结合碘125粒子植入治疗,60例)。观察两组疗效、肝功能指标[丙氨酸氨基转移酶(ALT)、谷草转氨酶(AST)、总胆红素(TBiL)]、血清肿瘤标志物[甲胎蛋白(AFP)、细胞角蛋白19片段(CYFRA21-1)及癌胚抗原(CEA)]、TSGF、TK-1、sB7-H3。随访3年,采用Kaplan-Meier曲线分析(Log-Rank检验)两组患者总生存期(OS)的差异。结果:联合组的临床总有效率高于对照组(P<0.05)。与治疗前相比,两组治疗后ALT、AST、TBiL均下降,且联合组均低于对照组同期(P<0.05)。与治疗前相比,两组治疗后AFP、CYFRA21-1、CEA均下降,且联合组均低于对照组同期(P<0.05)。与治疗前相比,两组治疗后TSGF、TK-1、sB7-H3均下降,且联合组均低于对照组同期(P<0.05)。联合组的OS长于对照组(P<0.05)。结论:TACE联合碘125粒子植入治疗PHC合并PVTT患者,可提高临床疗效,降低血清肿瘤标志物水平,减轻肝功能损伤,延长患者OS并调节血清TSGF、TK-1、sB7-H3水平。 相似文献
11.
Ling Wang Qi Zhang Wei Chen Baoen Shan Yang Ding Guochuan Zhang Nana Cao Lei Liu Yingze Zhang 《PloS one》2013,8(8)
B7-H3 is a member of the B7-family of co-stimulatory molecules, which has been shown to be broadly expressed in various tumor tissues, and which plays an important role in adaptive immune responses. The role of B7-H3 in osteosarcoma, however, remains unknown. In this study we used immunohistochemistry to analyze B7-H3 expression in 61 primary osteosarcoma tissues with case-matched adjacent normal tissues, and 37 osteochondroma and 20 bone fibrous dysplasia tissues. B7-H3 expression was expressed in 91.8% (56/61) of the osteosarcoma lesions, and the intensity of B7-H3 expression in osteosarcoma was significantly increased compared with adjacent normal tissues, osteochondroma and bone fibrous dysplasia tissues (p<0.001). Patients with high tumor B7-H3 levels had a significantly shorter survival time and recurrence time than patients with low tumor B7-H3 levels (p<0.001). Moreover, tumor B7-H3 expression inversely correlated with the number of tumor-infiltrating CD8+ T cells (p<0.05). In vitro, increasing expression of B7-H3 promotes osteosarcoma cell invasion, at least in part by upregulating matrix metalloproteinase-2 (MMP-2). In conclusion, our study provides the first evidence of B7-H3 expression in osteosarcoma cells as a potential mechanism controlling tumor immunity and invasive malignancy, and which is correlated with patients’ survival and metastasis. 相似文献
12.
Curiel TJ Wei S Dong H Alvarez X Cheng P Mottram P Krzysiek R Knutson KL Daniel B Zimmermann MC David O Burow M Gordon A Dhurandhar N Myers L Berggren R Hemminki A Alvarez RD Emilie D Curiel DT Chen L Zou W 《Nature medicine》2003,9(5):562-567
Suppression of dendritic cell function in cancer patients is thought to contribute to the inhibition of immune responses and disease progression. Molecular mechanisms of this suppression remain elusive, however. Here, we show that a fraction of blood monocyte-derived myeloid dendritic cells (MDCs) express B7-H1, a member of the B7 family, on the cell surface. B7-H1 could be further upregulated by tumor environmental factors. Consistent with this finding, virtually all MDCs isolated from the tissues or draining lymph nodes of ovarian carcinomas express B7-H1. Blockade of B7-H1 enhanced MDC-mediated T-cell activation and was accompanied by downregulation of T-cell interleukin (IL)-10 and upregulation of IL-2 and interferon (IFN)-gamma. T cells conditioned with the B7-H1-blocked MDCs had a more potent ability to inhibit autologous human ovarian carcinoma growth in non-obese diabetic-severe combined immunodeficient (NOD-SCID) mice. Therefore, upregulation of B7-H1 on MDCs in the tumor microenvironment downregulates T-cell immunity. Blockade of B7-H1 represents one approach for cancer immunotherapy. 相似文献
13.
目的:探讨共刺激椅子B7-H3在人不同非小细胞肺癌(NSCLC)细胞系和组织中的表达及其临床意义。方法:实时定量反转录-聚合酶链式反应及蛋白印迹法检测B7-H3在5种人NSCLC细胞系中的表达量,利用免疫组化法检测121例NSCLC、33例癌旁组织及36例良性病变组织中B7-H3的表达量,并收集患者临床资料,分析B7-H3与临床参数的关系。结果:5个NSCLC细胞系中均见B7-H3的表达,A549及SPAC-1中表达较H466、H1299及H460中表达较低;B7-H3在NSCLC组织中高于癌旁组织及良性病变组织(P0.001);分化程度高者平均IOD高于分化程度中、低的患者(P0.05)。发生淋巴结转移和未发生淋巴结转移的患者B7-H3的平均IOD之间存在显著性差异(P0.05)。结论:B7-H3在NSCLC组织中高表达,可能是疾病治疗或诊断的靶因子。 相似文献
14.
Tran CN Thacker SG Louie DM Oliver J White PT Endres JL Urquhart AG Chung KC Fox DA 《Journal of immunology (Baltimore, Md. : 1950)》2008,180(5):2989-2998
Fibroblast-like synoviocytes (FLS) and T cells can activate each other in vitro, and in vivo interactions between these cells may be important in rheumatoid arthritis (RA), yet FLS lack significant expression of CD28 ligands. We sought to identify molecules homologous to CD28 ligands that are strongly expressed by FLS, and documented strong B7-H3 expression on FLS and by fibroblasts of other tissues, which was unaffected by a variety of cytokines. Western blot analysis of FLS lysates showed predominant expression of the larger, four Ig-like domain isoform of B7-H3. Immunohistological sections of RA synovial tissue showed strong staining for B7-H3 on FLS. Cells expressing B7-H3 were distinct from but in close proximity to cells that expressed CD45, CD20, and CD3. Confocal microscopy of FLS and T cell cocultures showed localization of B7-H3 in the region of the T cell-FLS contact point, but distinct from the localization of T cell CD11a/CD18 (LFA-1) and FLS CD54 (ICAM-1). Reduction of B7-H3 expression on FLS by RNA interference affected interactions of FLS with resting T cells or cytokine-activated T cells. Resting T cells showed increased production of TNF-alpha, IFN-gamma, and IL-2, whereas cytokine-activated T cells showed reduced cytokine production relative to control. However, cytokine production by T cells activated through their TCR was not notably altered by knock down of B7-H3. These observations suggest that B7-H3 may be important for the interactions between FLS and T cells in RA, as well as other diseases, and the outcome of such interactions depends on the activation state of the T cell. 相似文献
15.
Background
Members of the B7 superfamily costimulate the proliferation of lymphocytes during the initiation and maintenance of antigen-specific humoral and cell-mediated immune responses. B7-H3 (CD276) is a newly identified member of the B7 superfamily. It has been shown that B7-H3 plays a significant role in regulating T cell response in humans and mice, but it is not known whether a counterpart of human or murine B7-H3 exists in porcine species.Methodology/Principal Findings
We cloned the porcine 4ig-b7-h3 gene using a blast search at the NCBI database with human b7-h3, RT-PCR and 3′-terminus RACE. Protein sequence analysis showed that the protein encoded by this gene contained 4Ig-like domains and was 90.88% identical with human 4Ig-B7-H3. Results of Dot-blot hybridization and RT-PCR showed that B7-H3 was broadly distributed in porcine tissues mainly as two isoforms, 2Ig-B7-H3 and 4Ig-B7-H3, of which 4Ig-B7-H3 was dominant. We further demonstrated that porcine 4Ig-B7-H3 was able to inhibit the proliferation and cytokine production of porcine T cells activated through the TCR pathway, similar to human B7-H3.Conclusion
We cloned the porcine 4ig-b7-h3 gene and demonstrated that the porcine 4Ig-B7-H3 serves as a negative regulator for the T-cell immune response. 相似文献16.
17.
Tsai-Yu Lin Tsung-Hsun Tsai Chih-Tien Chen Tz-Wen Yang Fu-Ling Chang Yan-Ni Lo Ting-Sheng Chung Ming-Hui Cheng Wang-Chuan Chen Keng-Chang Tsai Yu-Ching Lee 《Experimental Animals》2021,70(3):333
For highly conserved mammalian protein, chicken is a suitable immune host to generate antibodies. Monoclonal antibodies have been successfully targeted with immunity checkpoint proteins as a means of cancer treatment; this treatment enhances tumor-specific immunity responses through immunoregulation. Studies have identified the importance of B7-H4 in immunoregulation and its use as a potential target for cancer treatment. High levels of B7-H4 expression are found in tumor tissues and are associated with adverse clinical and pathological characteristics. Using the phage display technique, this study isolated specific single-chain antibody fragments (scFvs) against B7-H4 from chickens. Our experiment proved that B7-H4 clearly induced the inhibition of T-cell activation. Therefore, use of anti-B7-H4 scFvs can effectively block the exhaustion of immunity cells and also stimulate and activate T-cells in peripheral blood mononuclear cells. Sequence analysis revealed that two isolated scFv S2 and S4 have the same VH complementarity-determining regions (CDRs) sequence. Molecule docking was employed to simulate the complex structures of scFv with B7-H4 to analyze the interaction. Our findings revealed that both scFvs employed CDR-H1 and CDR-H3 as main driving forces and had strong binding effects with the B7-H4. The affinity of scFv S2 was better because the CDR-L2 loop of the scFv S2 had three more hydrogen bond interactions with B7-H4. The results of this experiment suggest the usefulness of B7-H4 as a target for immunity checkpoints; the isolated B7-H4-specific chicken antibodies have the potential for use in future cancer immunotherapy applications. 相似文献
18.
19.
Nagashima O Harada N Usui Y Yamazaki T Yagita H Okumura K Takahashi K Akiba H 《Journal of immunology (Baltimore, Md. : 1950)》2008,181(6):4062-4071
B7-H3 is a new member of the B7 family. The receptor for B7-H3 has not been identified, but it seems to be expressed on activated T cells. Initial studies have shown that B7-H3 provides a stimulatory signal to T cells. However, recent studies suggest a negative regulatory role for B7-H3 in T cell responses. Thus, the immunological function of B7-H3 is controversial and unclear. In this study, we investigated the effects of neutralizing anti-B7-H3 mAb in a mouse model of allergic asthma to determine whether B7-H3 contributes to the development of pathogenic Th2 cells and pulmonary inflammation. Administration of anti-B7-H3 mAb significantly reduced airway hyperreactivity with a concomitant decrease in eosinophils in the lung as compared with control IgG-treated mice. Treatment with anti-B7-H3 mAb also resulted in decreased production of Th2 cytokines (IL-4, IL-5, and IL-13) in the draining lymph node cells. Although blockade of B7-H3 during the induction phase abrogated the development of asthmatic responses, B7-H3 blockade during the effector phase did not inhibit asthmatic responses. These results indicated an important role for B7-H3 in the development of pathogenic Th2 cells during the induction phase in a murine model of asthma. 相似文献